×
Volver a Agenda
Session Chair(s)
Andrew Townshend
Senior Vice President, Alliance Development
Syneos Health, United States
Learning Objective : Describe the challenges and benefits of converting to a functional service provider (FSP) relationship and how to manage the process; Explain how structures must change within to support this relationship; Identify how to make this transition while maintaining regulatory compliance and therapeutic excellence.
Speaker(s)
Panelist
Peter A Carberry, MD, MBA
Astellas Pharma Global Development, Inc., United States
Senior Vice President, Global Development Operations
Panelist
Gregg Dearhammer
IQVIA, United States
Senior Vice President, Data Sciences, Safety and Regulatory
Panelist
Gary Thompson, MS
Medidata Solutions, United States
Vice President, Strategic Consulting
¿Tiene una cuenta?